ArticleJournal of cellular and molecular medicine2020

Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.

Peramaiyan Rajendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.